Surgical Treatment for Pulmonary Metastasis of Head and Neck Cancer: Study of 58 Cases

Ann Thorac Cardiovasc Surg. 2017 Aug 20;23(4):169-174. doi: 10.5761/atcs.oa.16-00269. Epub 2017 May 9.

Abstract

Purpose: Although the number of surgeries performed for pulmonary metastasis of head and neck cancer has been increasing, there have been few reports of the surgical effectiveness. We collected the data of surgeries performed in our facility in order to discuss the surgical performance and indication.

Methods: We retrospectively examined the prognosis and predictors for 58 patients with pulmonary metastasis of head and neck cancer who underwent a surgery in our facility during the 15-year period, from January 2000 to December 2015.

Results: The 3-year and 5-year survival rates were 54.2% and 35.7%, respectively, and the median survival time was 42.2 months. The disease-free interval (DFI) was less than 24 months and patients with oral cavity cancer were poor prognostic factors.

Conclusion: The effectiveness of surgical treatment for pulmonary metastasis of head and neck cancer was suggested.

Keywords: head and neck cancer; metastasectomy; oral cavity cancer; pulmonary metastasis; surgical indication.

MeSH terms

  • Adult
  • Aged
  • Aged, 80 and over
  • Disease-Free Survival
  • Female
  • Head and Neck Neoplasms / mortality
  • Head and Neck Neoplasms / pathology*
  • Humans
  • Japan
  • Kaplan-Meier Estimate
  • Lung Neoplasms / mortality
  • Lung Neoplasms / secondary*
  • Lung Neoplasms / surgery*
  • Male
  • Metastasectomy / adverse effects
  • Metastasectomy / methods*
  • Metastasectomy / mortality
  • Middle Aged
  • Pneumonectomy* / adverse effects
  • Pneumonectomy* / mortality
  • Proportional Hazards Models
  • Retrospective Studies
  • Risk Factors
  • Time Factors
  • Treatment Outcome